tiprankstipranks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market

Mangoceuticals, Inc. (MGRX) Income Statement

Compare
93 Followers

Mangoceuticals, Inc. Income Statement

Last quarter (Q3 2024), Mangoceuticals, Inc.'s total revenue was $133.37K, a decrease of -45.60% from the same quarter last year. In Q3, Mangoceuticals, Inc.'s net income was $-2.00M. See Mangoceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 731.49K$ 8.94K$ 0.00
Gross Profit
$ 431.50K$ 4.85K$ 0.00
Operating Expenses
$ 9.65M$ 2.00M$ 17.52K
Depreciation and Amortization
$ 24.89K$ 3.86K$ 70.08K
EBITDA
$ -9.19M$ -1.99M$ 52.56K
Operating Income
$ -9.22M$ -1.99M$ -17.52K
Other Income/Expenses
$ 6.47K$ -6.47K$ -53.28K
Pretax Income
$ -9.21M$ -2.00M$ -17.70K
Net Income
$ -9.21M$ -2.00M$ -17.70K
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -6.45$ -0.12$ 0.00
Diluted EPS
$ -6.45$ -0.12$ 0.00
Weighted Average Shares Outstanding
1.43M 17.32M 17.32M
Weighted Average Shares Outstanding (Diluted)
1.43M 17.32M 17.32M
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis